secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0000950170-25-097591
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics Corporate Secretary Melinda Lackey to depart August 15, 2025
--------------------------------------------------------------------------------

- Melinda Lackey notified company on 7/16/2025 of termination of consulting agreement effective 8/15/2025.
- She will resign as Legal and Administrative Officer and Corporate Secretary on the effective date.
- Departure not due to any disagreement with the company on operations, policies, or procedures.
- No additional severance beyond accrued but unpaid compensation through effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025097591/0000950170-25-097591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025097591/tcrt-20250716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-097591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer